The source of heterogeneity in the NF-κB composition of DLBCL is unknown but likely results from a combination of mutational heterogeneity, epigenetic heterogeneity, and heterogeneity in the microenvironmental stimuli that tumor cells are exposed to. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.